[ET Net News Agency, 30 March 2022] Hansoh Pharmaceutical Group Company Limited (03692)
said for the year ended 31 December 2021, net profit was approximately RMB2,713 million,
representing an increase of approximately 5.6% compared with the year ended 31 December
2020. The board recommends a final dividend of RMB7.32 cents (equivalent to HK$9 cents)
per share.
Revenue was approximately RMB9,935 million, representing an increase of approximately
14.3% compared with the year ended 31 December 2020. (RC)